Avideh Nazeri, Vice President of Clinical, Medical and Regulatory for Novo Nordisk UK, reflects on her journey through the ...

Renowned immunologist Dr Yang Liu shares his insights into the preclinical studies behind the development of drug candidates targeting the CD24/Siglec-10 pathway. He discusses the technical and ...

Disrupting F-actin in aged brains restored brain autophagy to youthful levels and reversed some cellular markers of brain ageing. Researchers at UCLA have been able to prevent filamentous actin ...

The findings offer a promising drug target to prevent progression to colon cancer by targeting abnormal cells early on. The role of the p53 gene in the pathogenesis of ulcerative colitis (UC) has been ...

In this Q&A, Simon Lovestone, Vice President, Global Head, Neuroscience Discovery and Translational Science at Johnson & Johnson, shares how they are leveraging the A/T/N biomarker framework to ...

Anirban Datta, Head of Discovery Biology at Verseon International Corporation, details how recent breakthroughs are bringing once-distant possibilities, such as testing drugs more efficiently and ...

article Harnessing the CD24/Siglec-10 pathway: immunotherapy innovation 17 October 2024 | By Dr Yang Liu (OncoC4) Renowned immunologist Dr Yang Liu shares his insights into the preclinical studies ...

We had the privilege of talking to Veerle d’Haenens, General Manager, Global Therapy Innovations at Terumo Blood and Cell Technologies. Her successful career has been driven by her creativity, ...

Researchers have developed a new AI tool which recognises that protein behaviour can vary by cell and by tissue type.

Anirban Datta, Head of Discovery Biology at Verseon International Corporation, details how recent breakthroughs are bringing once-distant possibilities, such as testing drugs more efficiently and ...

Researchers reveal that GPNMB could be an effective therapeutic agent to improve cardiac function and prevent heart failure. Researchers at the UCLA have identified the GPNMB protein (glycoprotein non ...

Listen to this episode to discover how microbiomics is being leveraged to translate gut microbiome findings into new therapeutic options. In this episode, titled ‘Leveraging “omics” for novel ...